The advertisement promotes Nucala (mepolizumab) as a treatment for adult patients with inadequately controlled COPD, emphasizing its dosing schedule and safety information.
Creative Information
| CID: | 26eecfa1-bd5c-4d07-994c-cdd6c71a098b |
| CRID: | 82_2108-916333 |
| Domain: | nucalahcp.com |
| Seat: | PP |
| Size: | 300x250 |
| Bid: | $29.79 |
| Timestamp: | 12/22/2025, 5:13:09 PM |
| Declared IAB Categories: |
Analysis
5 succeeded(100% complete)
| Task | Status | Last Updated | Duration | Actions |
|---|---|---|---|---|
| ad_analysis | success | 12/22/2025, 5:13:43 PM | 7.15s | |
| adomain_analysis | success | 12/22/2025, 5:13:40 PM | 2.84s | |
| adomain_capture | success | 12/22/2025, 5:13:37 PM | 0.08s | |
| ad_render | success | 12/22/2025, 5:13:36 PM | 25.63s | |
| brand_mapping | success | 12/22/2025, 5:13:10 PM | 0.13s | |
Analysis Results
Ad Format: banner
Brands: NUCALA
Sensitive:Pharmaceutical Products
Quality:Adomain not match landing page domain
| Size: | 300x250 | ||||||||||||||||||||||
| Data Transferred: | 1519.14 KB | ||||||||||||||||||||||
| Render Time: | 10.14 Seconds | ||||||||||||||||||||||
| Creative Inferred IAB Categories: |
| ||||||||||||||||||||||
| Creative Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Domain Inferred IAB Categories: |
| ||||||||||||||||||||||
| Domain Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Landing Page: | |||||||||||||||||||||||
| Total Ad Size: | 1540.30 KB | ||||||||||||||||||||||
| Requests Made: |
|
Advertiser Domain

Ad Preview
Landing Page

Creatives


